Anavex Life Sciences Corp (AVXL) — Strategic Asset Allocation Index
Anavex Life Sciences Corp (AVXL) has a Strategic Asset Allocation Index of 0.0% as of September 2018. Strategic assets (PP&E of $0.00 plus long-term investments of $-) total $0.00, measured against net assets of $20.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Anavex Life Sciences Corp Strategic Asset Allocation Index (2014–2018)
This chart shows how Anavex Life Sciences Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2014 to 2018. As of September 2018, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $20.49 Million USD. Explore AVXL cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Anavex Life Sciences Corp (2014–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Anavex Life Sciences Corp from 2014 to 2018, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Anavex Life Sciences Corp worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 0.0% | $0.00 | $0.00 | $- | $20.49 Million | ▲ +0.0 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $24.25 Million | ▲ +0.0 pp |
| 2016 | 0.0% | $0.00 | $0.00 | $- | $6.31 Million | ▼ 0.0 pp |
| 2015 | 0.0% | $1.25K | $1.25K | $- | $12.81 Million | ▼ -1.2 pp |
| 2014 | 1.2% | $2.25K | $2.25K | $- | $192.63K | — |